Machado-Joseph disease presenting as severe asymmetric proximal neuropathy

Journal of Neurology Neurosurgery and Psychiatry

Volumn 63, Issue 4, 1997, Pages 534-536

  Van Schaik, I N ^a   Jobsis G J ^a,b   Vermeulen, M ^a   Keizers, H ^a   Bolhuis, P A ^a   De Visser, M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Machado joseph disease; Neuropathy; Sca3; Trinucleotide repeat expansion

Indexed keywords

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DNA DETERMINATION; HUMAN; MACHADO JOSEPH DISEASE; MALE; NEUROPATHY; PRIORITY JOURNAL; TRINUCLEOTIDE REPEAT;

EID: 0030750914     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.63.4.534     Document Type: Article

References (18)

1. Rosenberg RN. Machado-Joseph disease: an autosomal dominant motor system degeneration. Mov Disord 1992;7:193-203.
2. Barbeau A, Roy M, Cunha L, et al. The natural history of Machado-Joseph disease. An analysis of 138 personally examined cases. Can J Neurol Sci 1984;11:510-25.
3. Sasaki H, Wakisaka A, Fukazawa T, et al. CAG repeat expansion of Machado-Joseph disease in the Japanese: analysis of the repeat instability for parental transmission, and correlation with disease phenotype. J Neurol Sci 1995; 133:128-33.
4. Tuite PJ, Rogaeva EA, St George-Hyslop PH, Lang AE. Dopa-responsive parkinsonism phenotype of Machado-Joseph disease: confirmation of 14q CAG expansion. Ann Neurol 1995;38:684-7.
5. Kawaguchi Y, Okamoto T, et al. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.I. Nature Genet 1994;8:221-8.
6. Maruyama H, Nakamura S, Matsuyama Z, et al. Molecular features of the CAG repeats and clinical manifestation of Machado-Joseph disease. Hum Mol Genet 1995;4:807-12.
7. Dürr A, Stevanin G, Cancel G, et al. Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular, and neuropathological features. Ann Neurol 199639:490-9.
8. Ranum LPW, Lundgren JK, Schut LJ, et al. Spinocerebellar ataxia type I and Machado-Joseph disease: incidence of CAG expansions among adult-onset ataxia patients from 311 families with dominant, recessive, or sporadic ataxia. Am J Hum Genet 1995;57:603-8.
9. Matilla T, McCall A, Subramony SH, Zoghbi HY. Molecular and clinical correlations in spinocerebellar ataxia type 3 and Machado-Joseph disease. Ann Neurol 1995;38:68-72.
10. Maciel P, Gaspar C, DeStefano AL, et al. Correlation between CAG repeat length and clinical features in Machado-Joseph disease. Am J Hum Genet 1995;57:54-61.
11. Cancel G, Abbas N, Stevanin G, et al. Marked phenotypic heterogeneity associated with expansion of a CAG repeat sequence at the spinocerebellar ataxia 3/Machado-Joseph disease locus. Am J Hum Genet 1995;57:809-16.
12. Takiyama Y, Igarashi S, Rogaeva EA, et al. Evidence for inter-generational instability in the CAG repeat in the MJD1 gene and for conserved haplotypes at flanking markers amongst Japanese and Caucasian subjects with Machado-Joseph disease. Hum Mol Genet 1995;4:1137-46.
13. Sakai T, Kawakami H. Machado-Joseph disease: a proposal of spastic paraplegic subtype. Neurology 1996;46:846-7.
14. Junck L, Fink JF. Machado-Joseph disease and SCA3: the genotype meets the phenotypes. Neurology 1996;46:4-8.
15. Schols L, Vieira-Saecker AMM, Schols S, Przuntek H, Epplen JT, Riess O. Trinucleotide expansion within the MJD1 gene presents clinically as spinocerebellar ataxia and occurs most frequently in German SCA patients. Hum Mol Genet 1995;4:1001-5.
16. Haberhausen G, Damian MS, Leweke F, Muller U. Spinocerebellar ataxia, type 3 (SCA3) is genetically identical to Machado-Joseph disease (MJD). J Neurol Sci 1995;132:71-5.
17. Higgins JJ, Nee LE, Vasconcelos O, Ide SE, Lavedan C, Goldfarb LG, Polymeropoulos MH. Mutations in American families with spinocerebellar ataxia (SCA) type 3: SCA3 is allelic to Machado-Joseph disease. Neurology 1996;46:208-13.
18. Silveira I, Lopes-Cendes I, Kish S, et al. Frequency of spinocerebellar ataxia type 1, dentatorubropallidoluysian atrophy, and Machado-Joseph disease mutations in a large group of spinocerebellar ataxia patients. Neurology 1996;46: 214-8.